Danish drugmaker Novo Nordisk is in exclusive talks to take a controlling stake in Biocorp, a French company specializing in developing and producing delivery systems and...

LyondellBasell, Technip Energies and Chevron Phillips Chemical (CPChem) have signed a memorandum of understanding (MOU) to design, build and operate a demonstration unit...

After building up manufacturing footholds outside the US, including in Australia, Kenya, South Korea, Canada and the UK, vaccine specialist Moderna is planning to build a...

Chemours has agreed to sell its glycolic acid business to PureTech Scientific for $137 million cash. The transaction is expected to close by the third quarter of this...

Climate change, energy crisis, the call for a more environmentally compatible production method and socially responsible action do not stop at the pharmaceutical and...

The Fill & Finish of biologic drugs is expensive and poses special technological challenges for CDMOs. At the German site in Hameln, Siegfried has successfully proven...

Science and technology group 3M has announced plans to invest $146 million to expand its biopharma filtration capabilities at manufacturing facilities in Europe. The...

Italian API producer Olon has started building a second facility at its Rodano site in Milan that will be entirely dedicated to producing ultra-potent compounds.

Germany’s Merck is investing €35 million in biosafety testing at its Glasgow and Stirling sites in Scotland. When completed – no date has been given – the company said...

PPG has announced plans to spend $44 million on upgrading five of its powder coatings plants in the US, Mexico and Brazil, to meet growing customer demand for more...